Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age

doi:10.1016/0895-4356(96)00027-3

Journal of Clinical Epidemiology

Volume 49, Issue 8, August 1996, Pages 821-825

https://doi.org/10.1016/0895-4356(96)00027-3 Get rights and content

Abstract

The objective of this study was to develop a clinical asthma score (CAS) for use in hospitalized children between 1 and 5 years of age. Formal approaches to item selection and reduction, reliability, discriminatory power, validity, and responsiveness were used. The final CAS consisted of five clinical characteristics: respiratory rate, wheezing, indrawing, observed dyspnea, and respiratory-to-expiratory ratio. Interrater reliability was high (weighted kappa = 0.82), and the CAS was discriminatory (Ferguson's δ = 0.92). The CAS was valid, with a strong correlation with length of hospital stay (Spearman's correlation = 0.47, p < 0.05) and drug dosing interval (Spearman's correlation = -0.58, p < 0.01). The CAS was responsive, with a significant change in CAS from admission to discharge (Wilcoxon signed rank test, p < 0.01). This score, for use in hospitalized preschool children, is reliable, discriminatory, valid, and responsive.

References (39)

G.J.A. Cropp
Special features of asthma in children
Chest
(1985)
D.A.W.M. van der Windt et al.
Clinical scores for acute asthma in pre-school children. A review of the literature
J Clin Epidemiol
(1994)
B. Kirshner et al.
A methodological framework for assessing health indices
J Chron Dis
(1985)
G.H. Guyatt et al.
Responsiveness and validity in health status measurement: A clarification
J Clin Epidemiol
(1989)
E. Kerem et al.
Predicting the need for hospitalization in children with acute asthma
Chest
(1990)
D.P. Skoner et al.
Pediatric predictive index for hospitalization in acute asthma
Ann Emerg Med
(1987)
S. Schuh et al.
Nebulized albuterol in acute bronchiolitis
J Pediatr
(1990)
D.W. Wood et al.
Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus
J Allergy Clin Immunol
(1972)
F.W. Moler et al.
Improvement in clinical asthma score and PaCO₂ in children with severe asthma treated with continuously nebulized terbutaline
J Allergy Clin Immunol
(1988)
J. Bishop et al.
Evaluation of the properties and reliability of a clinical severity scale for acute asthma in children
J Clin Epidemiol
(1992)

G.J. Canny et al.

Acute asthma: Observations regarding the management of a pediatric emergency room

Pediatrics

(1989)

R. Stein et al.

Severe acute asthma in a pediatric intensive care unit: Six years' experience

Pediatrics

(1989)

D.L. Streiner et al.

Health Measurement Scales: A Practical Guide to Their Development and Use

P.C. Parkin et al.

Randomized trial spacer vs nebulizer for acute asthma

Arch Dis Child

(1995)

E.R. McFadden et al.

Acute bronchial asthma

N Engl J Med

(1973)

J.O.O. Commey et al.

Physical signs in childhood asthma

Pediatrics

(1976)

E. Kerem et al.

Clinical-physiologic correlations in acute asthma of childhood

Pediatrics

(1991)

W.E. Pierson et al.

A double-blind trial of corticosteroid therapy in status asthmaticus

Pediatrics

(1974)

D.W. Wood et al.

A clinical scoring system for the diagnosis of respiratory failure

Am J Dis Child

(1972)

Cited by (70)

Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma
2017, Allergology International
Citation Excerpt :
They had been using bronchodilators on demand during symptomatic periods. Asthma symptom severity was based on a previously published asthma scoring system for young children.12 All clinical characteristics were scored on a 3-point ordinal scale (0, 1, and 2), with the total score consisting of five clinical features: (1) respiratory rate (<40 breaths/min, 40–60 breaths/min, >60 breaths/min); (2) wheezing (expiratory or inspiratory wheezing heard with a stethoscope); (3) retraction (subcostal or intercostals muscle retraction); (4) observed dyspnea (observer's impression of the patient's degree of breathlessness); and (5) inspiratory to expiratory ratio (I > E, I = E, I < E).
This study was done to compare the efficacy of a recently developed eosinophil-derived neurotoxin (EDN) ELISA kit (“BioTracer™ K^® EDN ELISA Kit”) to a commercially available EDN ELISA kit (“MBL EDN ELISA Kit”) and demonstrate the usefulness of serum EDN measurement in young asthmatic children.
Forty-eight children with physician-diagnosed asthma (Asthma group) and 31 age-matched normal controls (Control group) were recruited from the Asthma and Allergy Center at Inje University Sanggye Paik Hospital, Seoul, Korea from January 2010 to September of 2012. EDN levels in each serum specimen were measured 2 times using the: 1) BioTracer™ K^® EDN ELISA Kit and 2) MBL EDN ELISA Kit at the Inje University Sanggye Paik Hospital laboratory. EDN level measurements in each serum specimen were compared.
EDN measurements from the BioTracer™ K^® EDN ELISA Kit correlated well with those from the MBL EDN ELISA Kit: r = 0.9472 at the Inje University Sanggye Paik Hospital laboratory. These r values were considered both clinically relevant (i.e., r > 0.85) and statistically significant (p < 0.0001). EDN measurements from both kits positively correlated with asthma symptom severity (p < 0.0001). No serious adverse events occurred during the study.
The BioTracer™ K^® EDN ELISA Kit was accurate and useful in measuring EDN levels in young asthma patient serum. Because of our kit's distinct advantages and utility, we suggest this kit can be used for the timely diagnosis, treatment, and monitoring of asthma in asthma patients of all ages, especially those too young to perform pulmonary function tests.
The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children
2024, Annals of Thoracic Medicine
Initial emergency department vital signs may predict PICU admission in pediatric patients presenting with asthma exacerbation
2023, Journal of Asthma
Pulse oximetry respiratory monitoring for assessment of acute childhood wheeze
2022, Archives of Disease in Childhood
A pediatric hospital-wide asthma severity score: Reliability and effectiveness
2022, Pediatric Pulmonology
Proposed Assessment of Cough and Dyspnea in Children via Telemedicine in Coronavirus Disease 2019 Era: A Web Application—HOPS
2021, Clinical Pediatrics

View all citing articles on Scopus

^☆: This study was supported by grants from Physicians Services Incorporated (PSI #91-27), and Pediatric Consultants, The Hospital for Sick Children.

View full text

Original articleDevelopment of a clinical asthma score for use in hospitalized children between 1 and 5 years of age☆

Abstract

Chest

J Clin Epidemiol

J Chron Dis

J Clin Epidemiol

Chest

Ann Emerg Med

J Pediatr

J Allergy Clin Immunol

J Allergy Clin Immunol

J Clin Epidemiol

Acute asthma: Observations regarding the management of a pediatric emergency room

Pediatrics

Severe acute asthma in a pediatric intensive care unit: Six years' experience

Pediatrics

Health Measurement Scales: A Practical Guide to Their Development and Use

Randomized trial spacer vs nebulizer for acute asthma

Arch Dis Child

Acute bronchial asthma

N Engl J Med

Physical signs in childhood asthma

Pediatrics

Clinical-physiologic correlations in acute asthma of childhood

Pediatrics

A double-blind trial of corticosteroid therapy in status asthmaticus

Pediatrics

A clinical scoring system for the diagnosis of respiratory failure

Am J Dis Child

Original article
Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age☆